Surescripts names outsider as CEO


Surescripts named an interloper, Frank Harvey, as its CEO, the e-prescription corporate stated Monday.

Harvey, who maximum lately led private-equity investments for healthcare generation corporations at ATLS Investments, will take the helm June 27. He succeeds Tom Skelton, who in November introduced plans to retire.

Ahead of ATLS Investments, Harvey served as CEO of Mirixa, a generation corporate fascinated about drugs remedy control that used to be received through Cardinal Well being, and as CEO of Liberty Clinical Provide, an organization that sells prescribed drugs and different clinical provides.

“Frank is a results-oriented chief with sturdy operational abilities, and intensive enjoy rising healthcare companies,” stated Douglas Hoey, co-chair of Surescripts’ board of administrators, in a information unencumber.

Harvey in a information unencumber stated he plans to release new services and products at Surescripts.

Arlington, Virginia-based Surescripts is a privately held well being data change community best possible identified for routing digital prescriptions between healthcare suppliers and pharmacies. It additionally develops prior authorization, drugs historical past and different gear for well being techniques, well being plans, pharmacy get advantages managers, pharmacies and different generation distributors.

Just about 1.9 million healthcare pros finished 20.4 billion transactions at the Surescripts community ultimate yr, up 16.6% from 2020, in line with the corporate.

The corporate is protecting itself in a lawsuit introduced through the Federal Industry Fee in 2019 within the U.S. District Courtroom in Washington. Within the grievance, the FTC alleges Surescripts has monopolized parts of the e-prescription marketplace.

Skelton, who joined Surescripts as CEO in 2014, stated he would paintings with the brand new CEO throughout a transition length.